FDA reaffirms importance of yearly imaging follow-up after EVAR

The FDA has issued a letter to health care providers emphasizing the importance of annual follow-up in patients who received endovascular grafts for abdominal aortic aneurysm.
According to the letter, although endovascular aortic repair largely replaced open surgery for AAA due to lower 30-day mortality, death at 3 to 5 years is similar between treatments.
Guidelines on the care of patients with AAA from the Society for Vascular Surgery reported that physician and patient compliance with the current imaging follow-up recommendations is approximately 40%.
During the November 2021 meeting, the

The FDA has issued a letter to health care providers emphasizing the importance of annual follow-up in patients who received endovascular grafts for abdominal aortic aneurysm.
According to the letter, although endovascular aortic repair largely replaced open surgery for AAA due to lower 30-day mortality, death at 3 to 5 years is similar between treatments.
Guidelines on the care of patients with AAA from the Society for Vascular Surgery reported that physician and patient compliance with the current imaging follow-up recommendations is approximately 40%.
During the November 2021 meeting, the